Stocks

The table gives an overview of all stocks, alphabetically sorted.
 O-I Glass, Inc. OI Dec 1, 2020 11.95 +5.57   
 O2Micro International Limited - American Depositary Shares OIIM Dec 1, 2020 6.37 +0.32   
 Oak Street Health Inc OSH Dec 1, 2020 44.99 -4.62   
 Oak Valley Bancorp (CA) OVLY Dec 1, 2020 18.20 +1.56   
 Oaktree Acquisition Corp II OACB Dec 1, 2020 9.91 0.00   
 Oaktree Acquisition Corp. Class A Ordinary Shares OAC Dec 1, 2020 10.77 +2.38   
 Oaktree Capital Group LLC 6.55% PRF PERPETUAL USD 25 - Ser B OAK-B Dec 1, 2020 27.21 -0.66   
 Oaktree Capital Group LLC 6.625% PRF PERPETUAL USD 25 - Ser OAK-A Dec 1, 2020 27.21 -0.22   
 Oaktree Specialty Lending Corporation OCSL Dec 1, 2020 5.61 0.00   
 Oaktree Strategic Income Corporation OCSI Dec 1, 2020 7.74 -0.77   
 Oasis Midstream Partners LP - Common Units, Representing Lim OMP Dec 1, 2020 10.74 +1.70   
 Obalon Therapeutics, Inc. OBLN Dec 1, 2020 0.95 +3.54   
 Oblong Inc. OBLG Dec 1, 2020 6.96 -26.74   
 ObsEva SA - OBSV Dec 1, 2020 2.16 +1.41   
 Occidental Petroleum Corporation OXY Dec 1, 2020 15.13 -4.00   
 Ocean Bio-Chem, Inc. OBCI Dec 1, 2020 13.30 +0.38   
 Ocean Power Technologies, Inc. OPTT Dec 1, 2020 2.54 -11.81   
 Oceaneering International, Inc. OII Dec 1, 2020 6.48 +6.75   
 OceanFirst Financial Corp. OCFC Dec 1, 2020 16.19 +2.66   
 OceanFirst Financial Corp. - Depositary Shares OCFCP Dec 1, 2020 26.99 -0.55   
 Oconee Federal Financial Corp. OFED Dec 1, 2020 23.05 -6.60   
 Ocugen, Inc. OCGN Dec 1, 2020 0.34 +6.58   
 Ocular Therapeutix, Inc. OCUL Dec 1, 2020 17.96 +2.63   
 Ocuphire Pharma, Inc. OCUP Dec 1, 2020 6.12 0.00   
 Ocwen Financial Corporation NEW OCN Dec 1, 2020 23.49 -0.47   
 Odonate Therapeutics, Inc. ODT Dec 1, 2020 15.40 +2.53   
 Odyssey Marine Exploration, Inc. OMEX Dec 1, 2020 6.80 -1.45   
 Office Properties Income Trust - OPI Dec 1, 2020 22.78 -0.31   
 OFG Bancorp OFG Dec 1, 2020 17.15 +2.39   
 OFG Bancorp 7% PRF PERPETUAL USD 25 - Ser B OFG-B Dec 1, 2020 25.47 0.00   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
Free Trial Now